New research highlights prevention, diagnostic, and treatment advances for Alzheimer, autism, atherosclerosis, and more.
Sage Therapeutics and Biogen Officially Announce Ending of SAGE-324 Program in Essential Tremor
Episode 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease
Continued Progress in Phase 1 Study of Antisense Oligonucleotide ION464 in MSA
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Patients Highly Recommend Continuous Subcutaneous Apomorphine Infusion for Parkinson Disease, Survey Says
Extended-Release Amantadine Shows Reduction in Dyskinesia Severity for Parkinson Disease